Recent Patents on Anti-Infective Drug Discovery
Volume 15, 3 Issues, 2020
ISSN: 2212-4071 (Online)
ISSN: 1574-891X (Print)
This journal supports open access
Order Your Article Before Print
ISSN: 2212-4071 (Online)
ISSN: 1574-891X (Print)
This journal supports open access
In the current Pandemic scenario, all articles related to Coronavirus will be processed on a free, quick track basis, to ensure timely review and publication of much needed research
Contents
Recent Patents on Anti-Infective Drug Discovery, Volume 13 - Number 2
Biography Open Access
Editorial Open Access
Nanomedicine Advances in Topical Infective and Non-Infective Skin Diseases Therapy
, 13(2): 104Mahfoozur Rahman, Sohail Akhter and Sarwar Beg
DOI: 10.2174/1574891X1302181106123659
Review Article
Nanotechnological Carriers for Treatment of Acne
, 13(2): 105 - 126Shivani Verma, Puneet Utreja and Lalit Kumar*
DOI: 10.2174/1574891X13666180918114349
Nanotechnological Carriers for Treatment of Acne
Review Article
Current State of Nanomedicines in the Treatment of Topical Infectious Disorders
, 13(2): 127 - 150Kanika Thakur, Gajanand Sharma, Bhupinder Singh, Sanjay Chhibber and Om P. Katare*
DOI: 10.2174/1574891X13666180529103804
Current State of Nanomedicines in the Treatment of Topical Infectious Disorders
Review Article
Nano-Based Therapy for Treatment of Skin Cancer
, 13(2): 151 - 163Sadaf J. Gilani, Mohammed A. Jahangir, Chandrakala, Md. Rizwanullah, Mohamad Taleuzzaman, Mohammad S. Shahab, Kashif Shakeel, Mohd. Aqil and Syed S. Imam*
DOI: 10.2174/1574891X13666180911095440
Nano-Based Therapy for Treatment of Skin Cancer
General Review Article
Screening and Potential of the Incidence of Resistance Transfer Among the Multidrug and Heavy Metal Resistant Gram-Negative Isolates from Hospital Effluents of Northern India
, 13(2): 164 - 179Manzar Alam and Mohd. Imran*
DOI: 10.2174/1574891X13666180702111330
Screening and Potential of the Incidence of Resistance Transfer Among the Multidrug and Heavy Metal Resistant Gram-Negative Isolates from Hospital Effluents of Northern India
General Research Article
Evaluation of Fosfomycin Activity Against Extended Spectrum Beta Lactamase (ESBL) Producing Enterobacteriaceae Isolated from Three Centers of Tehran, Iran
, 13(2): 180 - 186Roya Ghanavati, Elnaz Ohadi, Hossein Kazemian, Fateme Yazdani, Alireza Torki, Behrooz S. Kalani and Gholamreza Irajian*
DOI: 10.2174/1574891X13666180517075803
Evaluation of Fosfomycin Activity Against Extended Spectrum Beta Lactamase (ESBL) Producing Enterobacteriaceae Isolated from Three Centers of Tehran, Iran
Patent Selections Open Access
Editor-in-Chief
Dieter Kabelitz
Institute of Immunology
Universitätsklinikum Schleswig-Holstein
Campus Kiel
Arnold-Heller-Straße 3
Kiel, D-24105
(Germany)
Biography
View Full Editorial Board
Institute of Immunology
Universitätsklinikum Schleswig-Holstein
Campus Kiel
Arnold-Heller-Straße 3
Kiel, D-24105
Biography
Biography of Dieter Kabelitz
Dieter Kabelitz is full professor at the University of Kiel, Germany, and Director of the Institute of Immunology. Previously, he was Head oft he Department of Immunology at the Paul-Ehrlich-Institute, Langen/Germany, and Associate Professor at the University of Heidelberg/Germany. Prof. Kabelitz has more than 30 years of research experience in immunology, with a strong focus on the functional analysis of human T lymphocytes. He has published more than 340 papers in peer-reviewed journals and edited or co-edited several books
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Recent Patents on Anti-Infective Drug Discovery was launched in 2006. Dr. Dieter Kabelitz serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.10
New eBook
 |
Frontiers in Clinical Drug Research-Anti InfectivesYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net